Valuable Links
Click here to download a useful tip sheet for patients regarding how to be successful with LACRISERT®. Print out and give to all of your patients receiving a LACRISERT® prescription.
The articles below offer important information about LACRISERT®:
- ARVO Poster: Study of Lacrisert® Dry Eye Insert—Significant Decrease in Ocular Surface Disease Index Eye & Contact Lens Publication: Improvement in Signs and Symptoms of Dry Eye
- Expert Panel on Dry Eye Syndrome—Provides insight into prescribing and counseling patients on optimal use
- Study of Lacrisert® (hydroxypropyl cellulose ophthalmic)—Dry Eye Insert at World Cornea Congress
- Study of Lacrisert® Dry Eye Insert—Published in The Ocular Surface
- Large Study of Lacrisert® Dry Eye Insert Patients—Experience Significant Improvement in Ocular Surface Disease and Quality of Life
The following Web sites* may help you learn more about your Dry Eye:
- The Sjögren’s Syndrome Foundation—Provides relevant information if you are suffering from Dry Eye due to Sjögren’s syndrome
- MedLinePlus—Provides a brief outline of Dry Eye and how it may affect you
- WebMD—Provides an in-depth explanation of Dry Eye
- eMedicineHealth—Offers detailed information about Dry Eye
- The National Eye Institute—Provides information about various eye diseases and disorders that affect Americans, including Dry Eye
- The Dry Eye Zone—Provides an interactive community offering a discussion forum and other information about Dry Eye
- Dry Eye Yellow Pages—Looking for an eye care professional in your area? The Dry Eye Yellow Pages provides a nationwide list of eye care professionals in one convenient location
Although not specifically focused on Dry Eye, the following links provide helpful information about Sjögren’s syndrome:
- The International Scleroderma Network—Provides information on Sjögren’s syndrome and online support
- Sjogren's World—Offers book reviews, a chat room, and discussion forums
LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Important Safety Information
Do not use LACRISERT® if you are allergic to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in a scratch to the cornea of your eye. Because LACRISERT® may cause temporary blurred vision, please use caution when driving or operating machinery. Rubbing the eye(s) containing LACRISERT® should be avoided. You should always discuss this safety information with your doctor. The following adverse reactions have been reported but were in most instances mild and temporary: temporary blurring of vision, eye discomfort or irritation, matting or stickiness of eyelashes, increased sensitivity to light, eyelid swelling, and eye redness. Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
*Aton Pharma, Inc. does not endorse the information contained on these Web sites. When you click on these links, you will be leaving the LACRISERT® Web site.
